Skip to main content
. 2015 Dec 16;310(6):F466–F476. doi: 10.1152/ajprenal.00288.2015

Fig. 14.

Fig. 14.

Effect of the administration of the CO donor CORM-3 on blood flow in the combined CKD-AVF model, assessed 1 day after creation of the AVF. Assessment of blood flow through the AVF (AVF vein) and the contralateral carotid artery was performed using a perivascular flow probe in mice, all of which were previously subjected to CKD and AVF and then administered either iCORM-3 or CORM-3. Determination of blood flow in the AVF vein and measurement of blood flow in the CCA were made as described in Fig. 2; n = 6 in each group. *P < 0.05, AVF-CORM-3 vs. AVF-iCORM-3; †P < 0.05, CCA-CORM-3 vs. CCA-iCORM-3.